Becker's Healthcare March 22, 2023
Noah Schwartz

Cognito Therapeutics, a neurotechnology company creating therapies for central nervous system diseases, raised $73 million in a series B financing round.

The funding will be used to advance a study of Cognito’s flagship neuromodulation device. The latest funding round brings the company’s total raised to $93 million, according to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Technology, Trends, Wearables
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers
Singapore tackling chronic diseases with wearables
Researchers use fitness tracker data and machine learning to detect bipolar disorder mood swings
Oura Ring Is ‘Like An Apple Product’ And Could Take Key Health Metric Mainstream
Wearable ultrasound sensor revolutionizes continuous blood pressure monitoring

Share This Article